Date: 2016-03-21
Type of information: Nomination
Compound:
Company: Adocia (France)
Therapeutic area: Metabolic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 21st, 2016, Adocia announced the formation of its new Global Diabetes Medical Advisory Board (MAB) consisting of well-respected endocrinologists from the US and EU. The MAB will serve as an ongoing key strategic resource to Adocia for the development of its expanding diabetes portfolio. In the near term, MAB engagement will focus on the development of BioChaperone Combo, a combination of the basal insulin glargine and the prandial insulin lispro, currently in phase 2. The inaugural nine-member board will be chaired by Dr. Jay Skyler, professor of medicine, pediatrics & psychology at the University of Miami. The medical advisory board also include Dr Vanita Aroda, physician investigator at MedStar Health Research Institute (MHRI), Hyattsville (USA) and scientific director of the MedStar Community Clinical Research Center, Dr. Bruce Bode, clinical associate professor in the Department of Medicine at Emory University, Atlanta (USA) and a diabetes specialist with Atlanta Diabetes Associates, Dr John Buse, professor at the University of North Carolina, School of Medicine in Chapel Hill (USA) where he serves as the Director of the Diabetes Care Center, Chief of the Division of Endocrinology and Executive Associate Dean for Clinical Research, Dr. William Cefalu, executive director of Louisiana State University’s Pennington Biomedical Research Center (USA), Dr. Dan Einhorn, MD, president of Diabetes and Endocrine Associates, clinical professor of medicine at the University of California, San Diego (USA) and medical director of the Scripps Whittier Diabetes Institute, Dr. Vivian Fonseca, professor of Medicine, Tullis–Tulane Alumni Chair in Diabetes, Section of Endocrinology at Tulane University Health Sciences Center (USA), Dr. Chantal Mathieu, diirector of the Endocrinology Clinic at the University Hospital of Leuven (Belgium) and professor of Endocrinology at the University of Leuven, Prof. Denis Raccah, professor at the Assistance Publique des Hôpitaux de Marseille (APHM) and director of the Department of Nutrition, Metabolic Diseases and Endocrinology at the Sainte Marguerite Hospital and the Conception Hospital (Marseille, France).
Financial terms:
Latest news:
